"Stable Injectable Compositions Of Glp 2 Peptide"

Orbicular Pharmaceutical Technologies Private Limited
Under Examination App No 202547041387 Biotechnology

Patent information

IP India · live record
Application number
202547041387
Filing date
29 April 2025
Status
Under Examination
Publication number
21/2025
Publication type
INA
Invention field
Biotechnology

Abstract

The present invention relates to a stable GLP-2 peptide injectable composition, comprising GLP-2 peptide agent comprises of sodium; wherein the GLP-2 peptide agent is teduglutide or h[Gly2]GLP-2 and one or more pharmaceutically acceptable excipient(s).

Applicants

1
India
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090, Telangana

Inventors

3
India
VALLABHBHAI, Patel BhaveshkumarOrbicular Pharmaceutical Technologies Pvt. Ltd. P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090, Telangana
India
KANNEKANTI, RaghuOrbicular Pharmaceutical Technologies Pvt. Ltd. P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090 Telangana
India
NIPPANI, Anjali DeviOrbicular Pharmaceutical Technologies Pvt. Ltd. P. No. 53, ALEAP Industrial Estate, Pragati Nagar, Kukatpally, Hyderabad-500 090, Telangana

Documents

Sign in to open
Application documents
1 202547041387-REQUEST FOR EXAMINATION (FORM-18) [29-04-2025(online)].pdf 29 Apr 2025
2 202547041387-POWER OF AUTHORITY [29-04-2025(online)].pdf 29 Apr 2025
3 202547041387-FORM 18 [29-04-2025(online)].pdf 29 Apr 2025
4 202547041387-FORM 1 [29-04-2025(online)].pdf 29 Apr 2025
5 202547041387-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2025(online)].pdf 29 Apr 2025
6 202547041387-COMPLETE SPECIFICATION [29-04-2025(online)].pdf 29 Apr 2025